Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AACR 2022
Pharma
AACR: Novartis makes case for canakinumab in lung cancer
The most important sign from the failed metastatic NSCLC trial that gives Novartis hope in the adjuvant setting lies in a subgroup analysis.
Angus Liu
Apr 12, 2022 4:05pm
AACR: Opdivo shows survival benefit trend in presurgery NSCLC
Apr 11, 2022 11:15am
AACR: Amgen fortifies KRAS lung cancer case with 2-year data
Apr 10, 2022 12:00pm
FDA goes direct to video with new cancer education push
Dec 1, 2020 9:17am
Amid pandemic, ASCO moves online while ADA plows ahead
Mar 25, 2020 2:45pm
Medical conferences get the ax amid coronavirus spread
Mar 11, 2020 10:40am
